Matthew Joseph Nachtrab Revocable Trust 2014 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-17 5:01 pm Purchase |
2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS |
Matthew Joseph Nachtrab Revocable Trust 2014 | 2,308 27.700% |
2,308 (New Position) |
Filing |